Option year 1, year 2 period of performance 08/24/2023 to 8/23/2025
Ended Awarded Last action
- Contract number
- 75H71024F26049
- Awardee
-
Mckesson Corporation UEI S1RUKWWRYFL6 Part of Mckesson Corporation
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $500,000
Award facts
- Contract value 67% obligated
-
- $500,000.00 Current, with exercised options
- $750,000.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Crownpoint, NM 87313, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $250,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $250,000 |
About this award
McKesson Corporation was awarded a BPA call valued at $750,000 by the Indian Health Service (IHS), a component of the Department of Health and Human Services, for a firm fixed price delivery of pharmaceutical and medical supplies to the Crownpoint, New Mexico facility. The option year contract covers the period from August 24, 2023 through August 23, 2025, with an ultimate completion date of February 28, 2026. This award represents a continuation of McKesson's established role as a critical pharmaceutical and medical supply vendor to federal healthcare agencies, leveraging the company's extensive distribution capabilities and product portfolio to support IHS operations serving Native American healthcare needs.
The contract was awarded without a set-aside designation, reflecting McKesson's competitive standing as a large business contractor in the federal healthcare procurement market. As the parent entity of McKesson Drug Company, the awardee brings significant federal contracting experience and established relationships with multiple government agencies, including the Department of Justice's Bureau of Prisons, Department of Veterans Affairs, and other HHS components. McKesson's existing indefinite delivery vehicles, including a $25.5 million blanket purchase agreement with the Department of Homeland Security's Customs and Border Protection, demonstrate the company's capability to manage complex, multi-agency medical supply requirements and support the federal government's broader healthcare and emergency preparedness missions.
Quick answers
Who was awarded contract 75H71024F26049?
75H71024F26049 was awarded to Mckesson Corporation by Indian Health Service (Department of Health and Human Services) on May 15, 2024.
How much is contract 75H71024F26049 worth?
The government has obligated $500,000 on 75H71024F26049. Its potential value, with all options, is $750,000.
Is contract 75H71024F26049 an order under another contract?
Yes. 75H71024F26049 is a BPA call under 75H71122A00161, a blanket purchase agreement.
Was contract 75H71024F26049 competed?
The extent of competition for 75H71024F26049 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award